The influence of plant saponins on the elasticity parameters of the great arteries in patients with multifocal atherosclerosis

Cover Page

Cite item

Full Text

Abstract

Background. Among the goals of pathogenetic therapy in patients with multifocal atherosclerosis, not only control of the intensity of atherogenesis, but also the elastic properties of the arterial system is becoming increasingly important, which opens up additional ways to reduce overall and cardiovascular mortality in this category of patients.

Aim. To evaluate effectiveness of medication Vazosponin (ZAO “Vifitekh”, Russia), which is a source of plant saponins in a dosage 400 mg per day, on the indicators of the elasticity of the great arteries.

Materials and methods. The study included 100 patients with multifocal atherosclerosis: those who had had myocardial infarction or percutaneous coronary intervention during the previous 2– 1 2 months and who had stenosing atherosclerosis of peripheral arteries – brachiocephalic arteries and/or arteries of the lower extremities. The main group – MG (n=50) consisted of patients who received combined hypolipidemic treatment: atorvastatin in dosage 40 mg/day + Vazosponin 400 mg/day along with baseline treatment. The control group (CG) included 50 patients who received only atorvastatin in dosage 40 mg/day along with baseline treatment. The observation period for each patient was 90 days with 3 control points (on the 1st, 10th and 90th days of therapy), in which were evaluated the elasticity indicators of the main arteries – pulse wave velocity, linear blood flow velocity, total peripheral vascular resistance, actual specific vascular resistance.

Results. There was a decrease in pulse wave velocity in both groups by the 90th day of the study, with a significant advantage in the group of patients who received Vazosponin: in the CG the indicator decreased by 7.3% (p<0.05), in the MG – by 19.3% (p<0.05). The decrease in linear blood flow velocity was 14.3% (p<0.05), in the CG the indicator decreased by 5.7% (p<0.05). The dynamics of peripheral vascular resistance indicators showed an obvious advantage in the group of patients who received plant saponins: in the MG of patients, a decrease in total peripheral vascular resistance was detected by an average of 11.0% (p=0.006) and actual specific vascular resistance – by 39.3% (p=0.0008), while in the CG – by 4.5% and 5.0%, respectively.

Conclusion. The addition of Vazosponin to the basic therapy of patients with multifocal atherosclerosis made it possible to achieve an additional increase in the elasticity of the arterial system, a significant decrease in peripheral vascular resistance, and the elimination of the “escape effect” of basic therapy. The data presented make it possible to consider the possibility of using preparations of plant saponins in combination therapy of patients with multifocal atherosclerosis who have instrumentally verified violations of the elastic properties of the arterial system.

About the authors

Alfred R. Bogdanov

City Clinical Hospital № 13; Russian State Social University; Pirogov Russian National Research Medical University

Author for correspondence.
Email: bogdanov.ar@mail.ru

D. Sci. (Med.), Prof.

Russian Federation, Moscow; Moscow; Moscow

Mariia E. Pyko

Pavlov Ryazan State Medical University; City Clinical Hospital №5

Email: bogdanov.ar@mail.ru

doctor

Russian Federation, Ryazan; Ryazan

Tatiana A. Romanova

City Clinical Hospital № 13

Email: bogdanov.ar@mail.ru

doctor

Russian Federation, Moscow

Yuri N. Fedulaev

Pirogov Russian National Research Medical University

Email: bogdanov.ar@mail.ru
ORCID iD: 0000-0003-4040-2971

D. Sci. (Med.), Prof.

Russian Federation, Moscow

References

  1. Kandaswamy E, Zuo L. Recent advances in treatment of coronary artery disease: role of science and technology. Int J Mol Sci 2018; 19 (2): 424.
  2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics 2012 update: a report from the American Heart Association. Circulation 2012; 125 (1): 2–220.
  3. Шальнова С.А., Деев А.Д. Ишемическая болезнь сердца в России: распространенность и лечение (по данным клинико-эпидемиологических исследований). Терапевтический архив. 2011; 83 (1): 7–12 [Shal’nova SA, Deev AD. Ischemic heart disease in Russia: prevalence and treatment (according to clinical and epidemiological studies). Terapevticheskii Arkhiv (Ter. Arkh). 2011; 83 (1): 7–12 (in Russian)].
  4. Балева Е.С. Оценка качества жизни в ракурсе оптимизации медико-социальной реабилитации больных ишемической болезнью. Автореф. дис. … канд. мед. наук. Волгоград, 2011 [Baleva ES. Ocenka kachestva zhizni v rakurse optimizacii mediko-social’noj reabilitacii bol’nyh ishemicheskojbolezn’yu. Avtoref. dis. … kand. med. nauk. Volgograd, 2011 (in Russian)].
  5. Nabel EG, Braunwald E. A tale of сoronary artery disease and myocardial infarction. N Engl J Med 2012; 366 (1): 54–63.
  6. Tomiyama H, Matsumoto C, Shiina K, et al. Brachial-ankle PWV: current status and future directions as a useful marker in the management of cardiovascular disease and/or cardiovascular risk factors. J Atheroscler Thromb 2016; 23 (2): 128–46.
  7. Морозова Т.Е., Вартанова О.А. Статины в лечении и профилактике прогрессирования атеросклероза у больных с ишемической болезнью сердца. CardioСоматика. 2013; 4 (1): 28–35 [Morozova TE, Vartanova OA. Statiny v lechenii I profilaktike progressirovaniya ateroskleroza u bol’nyh s ishemicheskoy bolezn’yu serdca. Cardiosomatics. 2013; 1: 28–35 (in Russian)].
  8. Lee SE, Chang HJ, Sung JM, et al. Effects of statins on coronary atherosclerotic plaques: the PARADIGM study. JACC: Cardiovasc Imaging 2018; 11 (10): 1475–84.
  9. Бойцов С.А., Погосова Н.В., Бубнова М.Г., и др. Кардиоваскулярная профилактика. 2017. Российские национальные рекомендации. Кардиоваскулярная профилактика. 2018; 6 [Boitsov SA, Pogosova NV, Bubnova MG, et al. Kardiovaskuliarnaia profilaktika. 2017. Rossiiskie natsional’nye rekomendatsii. Kardiovaskuliarnaia profilaktika. 2018; 6 (in Russian)].
  10. Гусев А.А. Сравнительное изучение биологических свойств сапонинов. Ветеринария. 1980; 1: 26 [Gusev AA. Sravnitel’noe izuchenie biologicheskih svojstv saponinov. Veterinariya. 1980; 1: 26 (in Russian)].
  11. Turgeon RD, Pearson GJ. Proprotein convertase subtilisin/kexin type 9 inhibitors for reduction of cardiovascular events. Am J Health Syst Pharm 2018; 75 (11): 747–54.
  12. Saborowski M, Dölle M, Manns MP, et al. Lipid-lowering therapy with PCSK9-inhibitors in the management of cardiovascular high-risk patients: Effectiveness, therapy adherence and safety in a real world cohort. Cardiol J 2018; 25 (1): 32–41.
  13. Zeki AI Hazzouri, Newman AB, Simonsick E, et al. Pulse wave velocity and cognitive decline in elders: The Health, Aging and Body Composition study. Stroke 2013; 44: 388–93.
  14. Шулутко И.Б., Тугбаева Л.Я., Нестеров В.А. Терапевтическая эффективность сапонинов диоскореи при лечении больных атеросклерозом. В кн.: Лекарственные средства из растений. Под ред. А.Д. Туровой. М., 1962; c. 143 [Shulutko IB, Tugbaeva LYa, Nesterov VA. Terapevticheskaya effektivnost’ saponinov dioskorei pri lechenii bol’nyh aterosklerozom. V kn.: Lekarstvennye sredstva iz rastenij. Pod red. A.D. Turovoj. Moscow, 1962; p. 143 (in Russian)].
  15. Милимовка М.Е., Коновалов М.Н., Рыбников М.И., Димат М.И. Опыт лечения больных атеросклерозом полиспонином. Врач. дело. 1963; 1 [Milimovka ME, Konovalov MN, Rybnikov MI, Dimat MI. Opyt lecheniya bol’nyh aterosklerozom polisponinom. Vrach. delo. 1963; 1 (in Russian)].

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Dynamics of PWV indicators in the compared groups (cm / s).

Download (102KB)
3. Fig. 2. Dynamics of the LBFV indicator in patients (cm / s).

Download (98KB)
4. Fig. 3. Dynamics of OPSS indicators in patients during therapy (dyn × s × cm-5).

Download (78KB)
5. Fig. 4. Indicators of UPSSf during therapy (units).

Download (77KB)

Copyright (c) 2021 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies